Skip to main content
Premium Trial:

Request an Annual Quote

Gene Logic Appoints Gessler President, COO

Premium

GAITHERSBURG, Md.--Genomics and bioinformatics company Gene Logic announced that Mark Gessler has been appointed to the new position of president and chief operating officer. Gessler formerly served as senior vice-president of corporate development and chief financial officer for the company.

Michael Brennan, Gene Logic's CEO, said the creation of the position reflects the company's maturation. "During 1998 Gene Logic experienced dramatic growth in both its genomics and bioinformatics businesses, adding nine new collaborations with pharmaceutical companies," Brennan said. "In his new position, Mark will assume primary responsibility for internal operations, enabling Gene Logic to continue on its path of rapid growth."

Filed under

The Scan

Billions for Antivirals

The US is putting $3.2 billion toward a program to develop antivirals to treat COVID-19 in its early stages, the Wall Street Journal reports.

NFT of the Web

Tim Berners-Lee, who developed the World Wide Web, is auctioning its original source code as a non-fungible token, Reuters reports.

23andMe on the Nasdaq

23andMe's shares rose more than 20 percent following its merger with a special purpose acquisition company, as GenomeWeb has reported.

Science Papers Present GWAS of Brain Structure, System for Controlled Gene Transfer

In Science this week: genome-wide association study ties variants to white matter stricture in the brain, and more.